MYC inhibitor DC-34
CAS No. 1966107-70-9
MYC inhibitor DC-34( DC-34 )
Catalog No. M13083 CAS No. 1966107-70-9
MYC inhibitor DC-34 is a potent small molecule that selectively inhibits MYC at the transcriptional level only when a G-quadruplex (G4) is present in the promoter.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMYC inhibitor DC-34
-
NoteResearch use only, not for human use.
-
Brief DescriptionMYC inhibitor DC-34 is a potent small molecule that selectively inhibits MYC at the transcriptional level only when a G-quadruplex (G4) is present in the promoter.
-
DescriptionMYC inhibitor DC-34 is a potent small molecule that selectively inhibits MYC at the transcriptional level only when a G-quadruplex (G4) is present in the promoter, binds to MYC G4 with Kd of 9.4 uM; does not transcriptionally downregulate several other G4-dependent genes to the same extent; binds independently to the MYC G4 3'and 5' ends, demonstrates cytotoxicity in L363 MM cells with IC50 of 3.5 uM.
-
In Vitro——
-
In Vivo——
-
SynonymsDC-34
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
Recptorc-Myc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1966107-70-9
-
Formula Weight446.47
-
Molecular FormulaC24H25F3N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(C)OC2=CC=C(O)C(CN3CCCCCC3)=C12)NC4=CC=C(C(F)(F)F)C=C4
-
Chemical Name4-(azepan-1-ylmethyl)-5-hydroxy-2-methyl-N-(4-(trifluoromethyl)phenyl)benzofuran-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Calabrese DR, et al. Nat Commun. 2018 Oct 12;9(1):4229.
2. Felsenstein KM, et al. ACS Chem Biol. 2016 Jan 15;11(1):139-48.
molnova catalog
related products
-
MYCi975
MYCi975 is an orally active inhibitor of MYC.MYCi975 inhibits P493-6, MV411,SK-N-B2 cells viability in an MYC-dependent manner(IC50s of 3.7, 3.9, 6.4 μM, respectively).The initial lead, MYC inhibitor 361 (MYCi361), suppressed in vivo tumor growth in mice, increased tumor immune cell infiltration, upregulated PD-L1 on tumors, and sensitized tumors to anti-PD1 immunotherapy. However, 361 demonstrated a narrow therapeutic index.
-
10074-G5
A small molecules that disrupts c-Myc-Max heterodimerization.
-
IRES-J007
An improved IRES inhibitor that blocks IRES-hnRNP A1 binding.
Cart
sales@molnova.com